However, in March 2025, Soleno Therapeutics marked a major milestone with the approval of VYKAT XR (diazoxide choline) , making it the first FDA-approved Prader-Willi syndrome drug for hyperphagia
If youre comparing your options, our Ozempic vs Mounjaro comparison can help you understand which GLP-1 brand might suit your situation best
Gastrointestinal side effects (nausea, diarrhea) may compound early in treatment
This supplement helps optimize your metabolism by improving mitochondrial function, increasing energy production, and supporting fat breakdown - making it easier to manage weight and reduce fatigue
Keep it cold
When evaluating semaglutide options (compounded via PlexusDx or branded Wegovy), genetic context can deepen the provider-patient discussion about likelihood of metabolic benefit, appropriate dosing escalation, and whether the peptide pathway represents the optimal therapeutic target for an individual